Nektar Therapeutics SEC Filings & 10K Form (NASDAQ:NKTR)

$20.15
-0.07 (-0.35 %)
(As of 09/22/2019 08:28 AM ET)
Add
Compare
Today's Range
$20.02
Now: $20.15▼
$20.76
50-Day Range
$16.85
MA: $20.26▼
$31.09
52-Week Range
$16.56
Now: $20.15▼
$62.70
Volume2.08 million shs
Average Volume2.72 million shs
Market Capitalization$3.53 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.7

SEC Filings

Nektar Therapeutics (NASDAQ:NKTR) SEC Filings

DateFilerForm TypeView
09/18/2019
6:07 PM		Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
4:09 PM		Doberstein Stephen K (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2019
8:50 PM		Nektar Therapeutics (Filer)
Form 8-K/A
08/27/2019
4:20 PM		Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2019
4:21 PM		Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
6:09 PM		Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
6:08 PM		Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
6:07 PM		Nektar Therapeutics (Issuer)
Nicholson John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
6:07 PM		Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
6:06 PM		Doberstein Stephen K (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
7:13 PM		Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
9:20 AM		FMR LLC (Filed by)
Nektar Therapeutics (Subject)
Form SC 13G/A
08/08/2019
7:26 PM		Nektar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
3:48 PM		Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2019
7:02 PM		Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2019
7:00 AM		Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2019
5:31 PM		Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2019
4:34 PM		Lingnau Lutz (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
4:50 PM		Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:29 PM		Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
10:15 AM		Invesco Ltd. (Filed by)
Nektar Therapeutics (Subject)
Form SC 13G
05/23/2019
6:19 PM		Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
7:22 PM		Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
7:22 PM		Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
7:21 PM		Nektar Therapeutics (Issuer)
Nicholson John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
7:20 PM		Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
7:19 PM		Hora Maninder (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
7:18 PM		Doberstein Stephen K (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
3:15 PM		Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
3:32 PM		Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:39 PM		Nektar Therapeutics (Filer)
Form DEFA14A
04/30/2019
3:33 PM		Nektar Therapeutics (Filer)
Form DEF 14A
03/12/2019
5:18 PM		GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
5:05 AM		Nektar Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2019
7:17 PM		Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
7:16 PM		Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
7:15 PM		Nektar Therapeutics (Issuer)
Nicholson John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
7:14 PM		Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
7:13 PM		Hora Maninder (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
7:13 PM		Doberstein Stephen K (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
11:00 AM		FMR LLC (Filed by)
Nektar Therapeutics (Subject)
Form SC 13G/A
02/12/2019
8:58 AM		Nektar Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
02/11/2019
2:03 PM		Nektar Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/06/2019
6:17 PM		Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2019
3:12 PM		Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2019
5:02 PM		Nektar Therapeutics (Issuer)
Nicholson John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2019
10:16 AM		Nektar Therapeutics (Subject)
OppenheimerFunds, Inc. (Filed by)
Form SC 13G/A
01/08/2019
10:30 AM		Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2018
5:14 PM		Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
5:13 PM		Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
5:12 PM		Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
5:11 PM		Hora Maninder (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
5:10 PM		Doberstein Stephen K (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2018
5:15 PM		Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2018
5:14 PM		Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2018
5:14 PM		Nektar Therapeutics (Issuer)
Nicholson John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2018
5:13 PM		Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2018
5:12 PM		Hora Maninder (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2018
5:11 PM		Doberstein Stephen K (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2018
8:22 PM		Nektar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2018
5:00 PM		Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2018
7:25 PM		Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2018
7:24 PM		Lingnau Lutz (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2018
7:23 PM		KUEBLER CHRISTOPHER A (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2018
7:22 PM		GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2018
7:21 PM		CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2018
7:20 PM		Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2018
7:19 PM		EASTHAM KARIN (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2018
7:17 PM		EASTHAM KARIN (Reporting)
Nektar Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2018
4:10 PM		Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2018
6:32 PM		Lingnau Lutz (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2018
6:31 PM		CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2018
6:29 PM		Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2018
6:12 PM		GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2018
6:32 PM		Nektar Therapeutics (Issuer)
WINGER DENNIS L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2018
8:47 PM		Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2018
8:46 PM		Nektar Therapeutics (Issuer)
Nicholson John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2018
8:45 PM		Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2018
8:44 PM		Hora Maninder (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2018
8:44 PM		Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2018
8:43 PM		Doberstein Stephen K (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2018
6:30 PM		Nektar Therapeutics (Issuer)
WINGER DENNIS L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
8:56 PM		Nektar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/10/2018
7:26 AM		BlackRock Inc. (Filed by)
Nektar Therapeutics (Subject)
Form SC 13G/A
06/27/2018
6:42 PM		Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2018
4:00 PM		Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2018
6:40 PM		Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2018
6:39 PM		CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2018
6:42 PM		GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
7:46 AM		Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2018
1:43 PM		Nektar Therapeutics (Filer)
Form CT ORDER
05/18/2018
6:07 PM		Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
6:06 PM		Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
6:05 PM		Nektar Therapeutics (Issuer)
Nicholson John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
6:03 PM		Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
6:02 PM		Hora Maninder (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
6:01 PM		Doberstein Stephen K (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2018
5:55 PM		CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2018
7:43 PM		Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2018
7:42 PM		Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/22/2019 by MarketBeat.com Staff

Featured Article: How to Calculate Compound Annual Growth Rate (CAGR)
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel